Opticyte
Company profile on P2PMarketData. Opticyte is a medical devices company based in Seattle, WA, founded in 2016. It has raised $286.6K through crowdfunding on StartEngine.
Opticyte is a medical device company founded in 2016 and headquartered in Seattle, Washington. The company's investigational VitalO₂ Monitor is designed to detect sepsis earlier by measuring oxygen in cells and provide accurate readings for all skin tones. Opticyte's technology has received FDA Breakthrough Device Designation and support from the National Institutes of Health, as sepsis is the leading cause of death in U.S. hospitals.
Frequently asked questions about Opticyte
How much funding has Opticyte raised?
Opticyte has raised $286.6K through crowdfunding across 1 round tracked by P2PMarketData, from 204 investors.
What is Opticyte's valuation?
Opticyte had an indicative valuation of $12.1M in its 2024 funding round.
Is Opticyte profitable?
No. Opticyte reported a net loss of $531K for fiscal year 2025.
How many employees does Opticyte have?
Opticyte reported 1 employee for fiscal year 2025.
When was Opticyte founded?
Opticyte was founded in May 2016.
Where is Opticyte based?
Opticyte is headquartered in Seattle, Washington, United States, and is incorporated in Delaware, United States.
What industry is Opticyte in?
Opticyte operates in the Medical Devices industry within the Healthcare sector.